biobanking BC Platforms Partners With Finnish Biobanks for Therapeutics Research The company, which has its R&D center in Finland, has won a multiyear contract with three biobanks to improve access to and management of genomic and other clinical data. Lifebit to Build 'Trusted Research Environment' for Danish National Genome Center The UK-based biotech firm signed a four-year contract to deploy its CloudOS software in support of the Danish program to sequence 60,000 genomes by 2024. Sema4 to Study Precision Oncology Disparities in Nationwide Biobanking, Genomic Profiling Study The firm will use its suite of assays to characterize samples from 5,000 advanced cancer patients from underserved communities and create a representative biobank. Pathogenic Variants in Disease-Causing Genes Have Low Penetrance on Average, Study Finds A biobank-based study estimated the penetrance of a number of pathogenic genetic variants to find their risk of causing disease is low. Gencove Expands Low-Coverage Sequencing Business to Ag-Bio Market Premium The company is planning to use a $10 million Series A financing to improve its platform and build data tools to make low-pass sequencing competitive. Nov 12, 2021 Childhood Brain Tumors in Crosshairs of New CHOP-led Sequencing Biobank Effort Premium Nov 8, 2021 Genomic Results Return Study Underscores Clinical Value, Takeaways for Expanded Implementation Sep 30, 2021 Multi-Ancestry GWAS Leads to Loci Linked to Hundreds of Human Phenotypes Aug 31, 2021 FinnGen Project's Role in Epilepsy, Drug Adherence Studies Showcased at ESHG Aug 30, 2021 NHGRI Awards Coriell Institute $4.6M to Manage Biobank Aug 20, 2021 Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities Jul 19, 2021 BioIVT Acquires Virtual Biobank Tissue Solutions Jun 24, 2021 Indivumed Launches Bioinformatics Platform, Expands Cancer Drug Discovery Efforts Premium May 7, 2021 Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research May 6, 2021 Coral Genomics Bets on Diverse Data to Advance Precision Medicine for Autoimmune Disease Premium Apr 29, 2021 Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk Apr 15, 2021 OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer Feb 9, 2021 European Project Sets Out to Harness Genomics Data, AI to Create New Predictive Tools Premium Jan 11, 2021 After Year of Scaling Up, Africa's 54gene Seeks Research Projects, Pharma Partnerships Premium Dec 24, 2020 IBD Polygenic Risk Scores Improved With Data From Multiple Ancestral Backgrounds Dec 17, 2020 Danish Researchers to Integrate Genomic Data With New Disease Trajectory Browser Premium Oct 26, 2020 GoodCell Raises $17.9M for Analytics Technology, Personal Biobanking Aug 21, 2020 UK Biobank Taps DNAnexus, AWS to Build Informatics Platform Premium Aug 4, 2020 Genuity Science Gains Access to BioVU With Nashville Biosciences Deal Jul 22, 2020 Alzheimer's Drug Discovery Foundation, Pharma Firms Form Biobank Alliance Load More Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.